CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison: JACC State-of-the-Art Review 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial Five-Year Outcomes with PCI Guided by Fractional Flow Reserve Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Dapagliflozin for treating chronic heart failure with reduced ejection fraction

Original ResearchVolume 42, Issue 12, 21 March 2021, Pages 1170–1177

JOURNAL:Eur Heart J. Article Link

Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes

D Csengeri, N-A Sprünker, RB Schnabel et al. Keywords: alcohol consumption; incident atrial fibrillation; biomarkers

Full Text PDF